12
. . - NIH NEWSLETTER 06 5 onud 3 nsnginu - riuuiuu 2551 VOL 5 NO 3 JULY - SEPTEMBER 2008

NIH NEWSLETTER - Ministry of Public Healthnih.dmsc.moph.go.th/book/vol5no3.pdf · n7snnaouqn@ubol@o Human Immunodeficiency Virus uwaqulurs nisnr~ouqnauuuado 2" t HN 3oar;uIws r8uni.j

Embed Size (px)

Citation preview

. . - NIH NEWSLETTER 06 5 onud 3 nsnginu - riuuiuu 2551 VOL 5 NO 3 JULY - SEPTEMBER 2008

~ d o ~ i a ~ d i l ' d i a ~ u x r i m & @ a ~ u w " d n i i ~ ~ n u ~ ~ n ~ ~ mmsmp u"~~~8~nau~mrdo~wuipinuniwuo~~nain douuu~&Gu~d~n'Y18o$?st11i~~g? 6 ~ ~ i l ~ a 5 v i ~ a # a $ u Iun~au~iuifudrilurn~a~iu a13 nis<~~ls:aurdonis ntjuuua;l ~ d h ~ ~ ~ . S 8 1 % ~ 8 n B ~ 1 ~ ~ ~ ~ d ~ 1 1 ~ 1 f ~ n ~ ~sriiu?arniw~a'oa~~~gniTnifm32qnizfinLBaLaq'1a~ ~un~iunu~si l+7 rdu wailoa uu~yu #+fro uuminrra nisarao?G~~uIsn~~dIstrldl~"R~ uniiir?ik iinruosu"u !T~U 'IlGh lfh8U U B E ~ T R ~ D Ln'7 dln &u?%#o?i 18~&4

o~vluiuh~a8u&dieau ~ n 7 fl n r u ~ n u ~ ~ ~ ~ w f n ~ s u w n u ' ~ r ~ w n ~ ' ~ d s r ~ u gnii~lsn~ostd clrp?unun~$aXudih ma l a f ia in7~ds~diTI BaL~UL7rP?dvrd*siryLii~nininiska

r i l u l ~ i u d ~ l l u r n ~ n ~ ~ ~ I ~ . w -&&.nn&bnni~$anw v ~ ~ I ~ ~ , z ~ ~ ~ I ~ R J I u ~ ~ L ~ u o ~ u ~ ~ T : ~ u ~ u d~fufld a" ~su~dara i~I~nraarFi iua2r i~~~n i~u3~En?ninimoa ~ n i Y " ~ ? i u ? n ~ i ~ i w m ~ m ~ i ~ ~ q ~ 1 d i u ~ 1 ~ i a r i l u n 1 s ~ n i u " u ~ u ? n u i c l ~ a r r ~ i m s n r ~ ~ ~ ~ ~ h w ? o ' u r ~ o n i nout~nun~1ur~dau~aim~~a6~ufiu P c y u ~ ~ ~ ~ n u d ~ ~ n u m ~ i n ~ I f n ~ l i u ~ ~ ~ ~ i i ~ 4~'Mriir~uo uiu5~Iiqj BU~UUIU~C 5Yuua%2uiini5ns:nsad

2.- = n~iuni~nri in~siainis~dmfi~ nisn~waufp~~uu.o'~~#a cnslmyv uarnot- ~~uistn.ilr"ounsu'inuima~fni~~wnu' Lon b ? n'~~vl"~iw~tA~al i~~unir inw~rnih~"ryu~~~ u a u ~ ~ u ~ 7 ~ ~ m a ~ n i u ~ a ~ ~ ~ ~ ~ ~ ~ n i d ~ ~ ~ i w i ~ d ~ i 1 u u lnuGi+tr<2 & ~ ? j i i v i ~ r r i ~ u n % : l k ~ ~ n ~ ~ ~ ~ z i ~ ~ u n m ~ e ~ u n ' ~ ~ :

UI ~ilua:I&~n'~f'~~s5n7iu~u~n~u LTTDi9tRU LYIIJIW~& r ~ u u i ; l n u ~ u u l n a i m ~ ~ ~ ~ ~ ~ ~ n u ~ ~ ~ m " 7 ~ ~ a u rsd fiuuiuinii3umlnnuin 8iirliiulrignS% l f i ~ ~ 1 m ~ f f ~ n ' i o i ~ i i I R ~ W I WIWIR&U

i i~uiuinq U~Z!JL$I~~$~~DJ~U~BJ"I~F)JLTII'IH)O V O L ~ ... . . unm7dn1~ *,.,,... . . I,.!,

~ ~ s t i u ~ % a ~ ~ ~ a u a ~ u l l d u o ~ ~ u 1 u z i 7 ~ i ~ ~ ' u # ., , . .... _ . . _ , ., .. * . . . .. .. u a n ~ n i t a ~ i n ~ l u i ~ m r ~ A a ~ w ~ 1 3 i n u n i ~ ~ ~ ~ ~ B ~ ' ''lii jii .... 1 uurun"lui l~nir ini .rau"~fu~~ u n i ~ u i ~ u ? n u i ~ i ~ 0 1 S :::::I

t ~inunnaiu'luns~riour-11n~wa~1:nm~un'aii~~ruaa

P S R I U V Q ~ ~ ~ Y ~ W ~ 1 ~ 1 ~ ~ ~ 1 ~ $ ~ 8 ~ ~ ~ ~ ~ 1 ~ ~ ~ 1 ~ 1 ~ 6 ~d w uan~inuua~~raau~ll~n?"d5trnn'11i. Ir '0~n~aiu~ii~diif i '~)

aa:muisnvi7l+r~5na'u~~iun"unv.l6~4~5u launini.mo~ "d - ~ n b s u G w ~ r r r m n d i s u a ~ ~ u r ~ a s u i n G a a ~ i ~ 5 u $ u a ~ 5 ~ aicmuazfiuiruuo~fiwdI~~u ~ l L ~ ~ J ' 1 1 ~ J ~ l ~ n l ~ d ~ ~ % . I 3, ~ ~ u ~ a a i q u n ~ $ d l w ~ u G w ~ u 6 ~ u Ka~ursinasui n'in2iui~n~u~mjniiiiw1unquX do4a: I~ i~ngaa~u~a ~ ~ u ~ a ~ ~ a ~ ~ ~ a ~ ~ u ~ d a a 6 u ~ ~ o l ~ 9 ' u ~ ~ Tnu~ndlah~~i$as nu iu fh~n~ ia$ lu Phylum Arthropods ~%wwd<i??rg Ra ~ i ~ 2 i a a b ~ : ~ ~ ~ l J ~ d ~ ~ ~ 0 ~ ~ 1 ~ ~ ~ ~ ~ n ~ ~ ~ . I r ' ~ 1 1 a " ~ iibna4 i i~rr~~via(aniuuan$aiauln~i i~i~mBPr (ch~t~n) riJu i4audarnn.u nir~a~rgr~u~m<a~oiR"uni~aonnmu ii01-h Phylum ~ds:nau6~u~sG~i~d i ina iuy1a inna iu d r s i f$ni~u6ln'~rriw~nuuaad~fl 6 '111 %an~~uua:!s%~ii 8

dl u i r ~ a : ~ m i ~ u ~ d i j u u i ~ Z ~ ~ ~ u u ~ I n " r ~ r i uu~yu M U J ~ D J

01:uiu r%ija rruamima $ 5 4 f l riluKu * 2.A- d ~wiuiuonuw~n~-11wu~r;iu~6Lia~~ra~$~oni~~~1ui

fi FumslunirmnlvY d~znaunia 2. UUUYU (Spiders) ~ilu~mdlabff~ul6n"a~an ij

uinuiunaiunirn O"RuR:~uinuwndisn"uld i iKauo~

1. rru~iloa (Scorpions) iio@auZunaiuaQw $4

'̂ ilaaO~~uuuoanr~n~~awi:d aanqnasio~zuuds-ain aazaiinG~aiuujrZom ~dldu~3"~iw~urli laaazIdiioinis 2mq u i $ d u ~ u i n a r i ~ ~ s i n i . r m i u ~ a u 4 1 i ~ ~ ~ T m u ~ ~ w i ~ odisislu~Gn qw~~awi:drda~nuuailo~oiau~~ilziimnis d2nu2uun.3 d 2 ~ k ~ ~ d a w f ~ ~ rUusoulnrJ' Gu iui &2u qn&iaa-uunlszsnn ua:ri7uRiuru'mr6om5a $d2ua:iiI$

.a ndula" oir5uu nmnrKuiMTaRn~~uu dau~iwiuardou ~ i a i u n ' i ~ ~ u ~ a ~ u n ' i l + r ~ i w i d i ~ n l n a uarGiaiulna uin ua:~dofiwrui~ns:u~Ta~wr~~2 o:vl"i'L~~'iju~di~quin i a & r iu 42a3u Eiuwinuisc-i2u a5nnisnsr?nuo~nn'iu

w(wK~&~ a n i W ~ m s n w ] u n~u3nmfliec6msw Ofl 5 &ufl 3 nmiw - tilrcliclu 2551

tilunzfl?; ~~a:niuladiuin uu~~udwuZ~d~~an~lnuuia %an r9iusiinniusuqiii (Tarantula) uonaine:%n"?u ru$oa%war&a uu~o~uuniuuuuo~iiaurio~ ai?KuKqner ~ ~ ~ 5 w a i n i s r r w ' a ~ i a ~ ~ r r s a 1 m u a : i a i n i s ~ u ~iluduuiu naiu~dni$ w ~ ~ n i r i i ~ m i a ~ ~ i \ ~ m i ~ n r a u ~ d i a f u ~ ~ ~ ~ ~ ~ h u u u a r ? u r r s j w ~ u ~ i ~ i i ~ w ~ i ~ u ~ 6 ~ m u a ~ l d ~ u l u ~ u 1-11 ~ ~ ~ M ~ J ~ ~ ~ ~ ~ M % ~ I ~ ~ W A ' I ~ ' U Z D ~ R ~dlI~LI~l l%Vld ~ n n ' n r r a : l ~ ~ i ~ ~ ~ r w a ~ ~ d ~ n f i i m a ~ ~ i u u ~ ~ ~ w r r ~ t r l m ~ M W R O ~ ~ U ~ M G J 9'ud~:n?Mui~z~uIIasr n?rri47~#au3r7ru d r r u a l i l u i i n r ~ o i ~ a ~ ~ ~ + s ~ a ~ 8 o u u n ~ i s u d r j ~ ~ $ ~ ~ c ? n ~ ~ ~ rmsnGou f i i i o i n i s u w ' f i ~ a ~ 7 ~ ~ u u ~ s ~ ~ ' I ~ w ~ ~ . n d

3. RWW ICentipedes) ~~uiimidwuldi4itrlarr.1ia iaudu G & u u i e r ~ ~ n ~ r w ~ ~ u ~ h ~ Ta@"ar w . 1UBJbt%%l@l . -. ' A, . .. l ~ q j a r ~ ~ ~ f i w m n dqBT-i~ e~or&udiSn~s~ruu~i~f~~in . .

6iu~uaifui6iuPi7~ E ~ & I ~ u ~ ~ J B ~ ~ " J ~ ~ T da"~ildiG2 G<IM-JU~~M~ I&@ Il%:.(~d*&g.O~i * : . . , ,.. .. 1 $ Iwuu~

. . .. . . .

vnri

;auajmiud$u ~~ainai~iua:siauZ~o$miuna~!li oan dirwfinlur~ainai~flu aruiuvl'ia'unsiunu~~unisK~r~a: ddou~i~ur$i!dlu5oudn'm ~da~nocuier~m~zwusou 2 ~uu~ra~sau~~nw~zrilu~nr8omoaner'~~~mn"~nn'a Gw

u o a r n ~ u i ~ 0 ~ n " i ~ % $ ~ i n i ~ d ~ m o r i i ~ + 1 ( ~ s ~ ~ r a z e l a a ~ f l u n a i UIUM~IU&-J~UJ 'I~U<.&I~ u~~nmd~n~ea:u?uraRJ urud-~~s'nuw'ia.ni lu~duw'Aw~~f lain~m~:~uns-17u ndu l i a i r h u duaa hwFS%w rra:%als~$u~% mzsliu w ~ n d i j ~ u i m l ~ ~ ~ r n ~ d ~ w u i n ~ d a ~ m u & ~ m i ~ i ~ n ~ i ~ % ~ u un:Bnimiu!k ~dannazuiun'rn~$8i~uwa~$r~oirn nnz

pa., * % ! . .- 'i::.;

@

% * ds:nlruuam'~uuinr~a~~ou.r~~nioini~dam n iu iw ia~a id ..

5. rruomincrn (~orse-shoe crab) vi%onulllrriio I d ~ 3 r ~ ~ d O n n ' m r ~ o i l n ~ n ' u n i s 6 m r . a o n n o i I % r ~ n ~ u a ~ ~ru~min ju M~OKUJWI!~ +a LM-51 d u u i m l ~ ~ d s : u i ~

unmGau ni~?mlnn~w%d.r~niuuist~uoinis~?n dii$ 6 %1 ~ 1 J l r ~ ~ n a u k ~ u w i a ~ ~ u u w ~ i ~ n n a u u u NU!$$

oini~~uusabur~mm~iu~mdn6~u.r:uuwiut~ bEu!d 8unrr~~ib;udriluAu~nau $?udrguR&a~darraz!4ivo~ wur~nnd uuami ainisuoaidIn%$wk ~:i3sini%.aiddin dan

.4. iaiia (Milipedes) L ~ M ~ ~ ~ ~ W Y U W ~ ~ ~ Z ~ I L I Q ~ ~ ~

Tan ;di i~i j~nwrumaaui~ ft~SiZ~niuuenu~aua;ii8Hu una iiK-dfid~oawniud8o~ rtd~rdgajas6jm 2 fj u?~m<a nuaouurn6~od<ud ~ m u d n A f i ~ f i o ~ r b ~ ~ ~ i u p ~ u ~ m u n i ~ fimwion'niiurirn$du ~ d a t s i n o i n i w o a ~ ~ ~ o ~ o ~ 9 . a f i 3 i i ~

J

w " ~ $ ~ ~ i ~ v i ~ n ~ a r W n ~ i l u 5 u w i m I ~ ~ ~ ~ a w i : ~ i ; ZunCmf a; &i5~1u~iuniswu ~ i i u LGI~IIOIZULL~;~IJ~~~ ;

4 ~ilu<iwawuinZwyuamu ~ i ~ ~ ~ ~ ~ n n l 3 ~ ~ ~ d 2 ~ ~ ~ a " 9 ~ d i ~ u in r r i n i u i s n ~ ~ ~ K w n i . r ~ n ~ d u n ' a ! n T n o n ~ u r ~ a ~ i dnnp\%9s.%n % ~ ~ 7 s ! i ~ u a ~ n i n i u ~ ~ u a : ~ ~ a 0 j i r i d ~ 1.n'i!rllwu?ra~dii~8u ~$o~nrGun'n!inasff~duaonni4 - ~ w n ~ a r ~ 1 ~ v i ? u d i n u 0 ~ ~ C i ~ u ' ~ n ~ ~ m 6 i ~ ~ ~ n"iwuijoin1s 8. \~T%R (Scabies mite, Sarcoptes scabieo nd0I-s

z - 2 iindn6a~~d2eraox~n.da~$ er&Jwuuwd aiinnd~ 8 Y? <i<a%~i-~ ~~YUIR 0.2 ija9~ums rn~: ! i m u i s n u o ~ ~ ~ ~ ~ a j l n ~ ~ u e r i r I I ~ i 1 6 r ~ m ~ r ~ i i ~ ~ i l w r f i ~ ~ ~ n ui2ta"nr) r~ii$u SiK~i?llo~Wsij%nwwna&w~~i~rlnn~,u iiadsaariu6uuiwKu uirilu~ua3nq fgu8u &Sail: o ~ ~ u ~ r a z w r u ~ f i i u u w f ~ n ~ ~ ~ o ~ n u . rdawru~wfuij? &@~zsiu ~ a w i r i i m 6 ~ r i j u r u i i $ ~ d a z t ] ~ ~ i a ~ ~ ~ ~ ~ Z w ~ ~ n M ' ~ ~ iw&ua~rn~aaz ra i r~ f i u lws~au ' i I d ' l u fa~M '~L~raw i : " w A , i3awu;rnaarauarui rdw Jiufiaija i iub?rni GoGo ur8o n300Tu~t~wn n i s ~ ~ ~ ~ ~ ~ o ~ j i n $ u ~ i i n a i n n i ~ K a ~ a ~ ~ i h a i ~ ' u a ~ l u a i a ~ . i i 3 u & d i o ~ ~ i ~ d r B u f i ~ s ~ u ~ ~ r l a o u ~ ~ ~ u r i i ~ ~ ~ n ~ i ~ i l ~ f i a ~ M ' ~ & ~ w u ~ n i j S n i n l ) ( ~ ~ r ~ w

7. KT~UGIY~U ( House dust mites) bfiu~a1~dmu ~ a u 9 i ~ ~ u a ~ ~ i l w ~ u ~ m a ~ s ~ u ~ ~ & d w ~ ~ ~ ~ u a r a r ~ o i n i s ~ w o i ~ ~ o ~ ~ u f i u f i o u rilwkdiju~inriin wud:~~u~rig~iyqu a d i ~ ~ u r n a n i ~ r n i t r ~ a d ~ n ~ ~ ~ m a i r a i - 3 ~ 1 t ~ ~ i i n n i s ~ n

a - 4 .d

n~~Zw~iufnotawiz~uuuduaw nuonr &SOJ r ~ a ~ ~ ~ n n ~ s ~ ~ ~ u ~ a n " i ' t ~ ~ ~ n M ' ~ ~ n ~ r ~ ~ ~ ~ n w ~ ~ ~ GGi uou u a z ~ i u w s ~ d ~ ~ i l w d ~ n " u ~ u 1 n ' ~ $16-~uo.s1'jquii rmEjo~Pnnnffafi~bianaan n i~ i l a~ i iumuisn~ i l&sun is %mm:nru3 'duia(1w i lq i 4 6 iia~M'~rB~saadunGilU li~uUPR$n&~iiuKu$il2u ni~~iiril~Ser\nY.n'~i~uu%a , :

mofiud&l4a ~ i i s d ~ n a i u ~ ~ ~ r i o Z ~ ~ i i n i l ~ v ~ i ~ ~ I a n ~ o ~YM~DBI~M (Benzyl benzoate) 25% 'lu$imd uar 12.5%

~sijuorusu Dermatophegoides M a e r n z ~ ~ q u ~ ~ s d D. tut Wn Is,uni UI M Sqai n aiu& uga f i . ~ I ~ a ~ I J $0 u 24

pteronyssinus f i +uoa~n~~$~~~d lwdrz rnn Inu oinis &a'ala~u&dou~"7~oofl f i ~ ~ ~ u i n a i a a ~ & ~ n i ~ i ' I w 3 n 5

uo~!.r~un"arnw~nsuw8a%M'~qo~.@w ~rar%unuun& iu6oui ~ u n s r i i d ~ ~ n ~ o u i n w i a ~ ~ a 1 n i m n i u r n " o ~ ~ ~ a ~ ~ w ' 8rw: ~ s ~ u u i u r 8 ~ 6 a n i a & i ~ i ~ ~ w n i s ~ ~ e r a i s r i ~ ~ ~ u w ' u i I n ~ u ~ i ~ ~ ~ o o n u ~ i n ~ n ~ ~ ~ w " a ~ s ~ w u ~ ~ ~ n u ' niohhu&au ~~slumidat:wu~$lrnr6~11~'~~~~~ snnIsd 9,

eriu ~rg2 s a ~ ~ ~ ~ o ~ $ e r # ! x ~ u ~ u r i i u o ~ n u ~ $dtviiurqa ~a nai'sai030 , - A ink$% da4&%9z$ni iuaiu~?~~~~azbf i%d~ ,, Bnlnl m n ~ H . nganalnlJn1511Wn~M~5W~LLWn~

s ~ ~ n & ~ 6 . o i n i r a i u $ ~ ~ n I ~ a i-~u$duriuin qa~a: nruzrnwas uni^anui&'ruiusl~ni~~~i rs&pys ;, u i s r i o ~ B ~ ~ ~ i n l ~ ~ ~ ~ i l u ~ ' ~ ~ ~ u ~ u ~ ~:vR¶M"rviriluTsn 2523, 23,

pguw'rfa~~ qu6~rBuTrnnouQidci s l i n ~ s g o ~ i n w 2. uuJnlnzu. isQ~9vtl ; [sl,gu 7,Ufl: ,jl %<.. , . ..:' 1 tnr~n lL I~~~l l4 ~ ~ ~ w ~ ~ ~ I J ~ ~ ~ ~ J ~ ~ ~ ~ & B J ~ ~ ' I ~ ~ ~ u

331% w w w . a s i & ~ r t , @ m l a ~ t i ~ l e s ~ ~ ~ ~ ' . . uJilaJ, rsa&&f ; &,

* :. ,aaatlart:f*)iBf&h

y&q@ ;&,n"*;f ra.at, w?l ; r*&\n' . . :: . , . :,,,,-wmIinh,wwI& *. ., .

. . , . , .., . ,

. . . . . . , ... , , , . .,.. . . .~ . . . . . .

00nvwti-a & W m ~ ~ u n s U 3 ~ m s n M I ~ WI s omd 3 mqm~ - ~ W U U 2 ~ 1

. , . . . .,

~. , . , . . . , . , .

5. It+*; @@W: : *&$A 7 %i&< mSt] ; .I&& P. m : , , ~ ~ u & y m ~ Y Y d m , j .*, !.:"

?*.-@,n"rl .: i-@,& . p w.&.,-*l ; : , &=& h ~ t p : / I w w W r z e e . h a ; r r a m t t t ~ a t ~ e $ ~ c F ' n r ' &q!7&*"2~58&,' ; !... > ~ . . # .>,, ~ .,., WL.

~.. .

,' , . '.'

..- I .-..a .. ..:::--*. -.* . k ._-. I- .. .*. -

1

myln ainisfiaayn ~ i lua in i~dr~aoinoin irb~iau B ~ J ~ i r n ~ u ~ ~ i n n i s i u ~ ~ ~ ~ ~ ~ o i n i r d ~ o u u i n ~ ~ ' i ~ ~ n r d a ~ ~ i nir

~u&rinuld~i9jiniliY'~rii11no~~~u~~n~ini1~niulJt n3aaioriinoinoirunid~rdrdsaulnin~d 5ria lr i~ i iaaini~Ca~ tnlvi'rduiiu ~ d o i l a i n i r n " n ~ ~ n a : k ~ n ~ ~ I $ i ~ i u q l;nuqi~o~r~~:rilun'ouu%~ iioinirn'o~8n rbjnriiuoonuioioo~n'il~'~ . ;

nai~Cnuinua:drlaaoonm' sz~udauo~niruo~rliiiin~'idn~n 3 dsrnis #a unuamijuoin~r Liouaini~ ~a~Y'ur i i~n ina iv i l i BJLOUSZUU

' . h 6 ~ ~ n ' l ~ ~ l d l ~ ~ ~ ~ ~ > ~ ~ ~ ? N ~ ~ a l W 1 ~ ~ d ~ ~ ~ L ~ ~ R ' d i ~ ~ ~ a ~ j l ~ n i u I a ~ u m r o i n ~ . ~ ~ ~ ~ z ~ ' ~ I J Z ~ ~ n i m i o ~ I u ~ . i l ~ i a ~ a ~ i7~niu~riqnuuu;sni h u n i n o i n ~ ~ d l n t a ~ o : ~ n ~ u o ~ n o i n i ~ ~ d ~ ~ ~uni¶daus?mi~~dia~o7tua~6dr:n~1~ri.1n'ry da din no Y I R O R ~ I W I ~ nr:rwi:aini~ i i l k ~ i n i i M n d 1:miww u~trni-amik hudaiu?tdurilu&d?dun~51ou Wa gu $u d a u ~ i a i u K U ~ O D M U ~ Z ? J & W n ~ u ~ ~ n i ~ d o ~ ~ a ~ ~ ~ & ~ ~ o ~ i ~ r ~ ~ ~ : r i i ~ u d ~ i 1 r r ' ~ ~ ~ 1 u 1 w " ~ ~ 8 o ~ d o u ~ ~ : . . ~ ~ . ~ . . .. .

~. via&~vrlosn"wr5~iiIir' niru~nJunlunianr:~unis~nda~I~~~o~i~Iw" ~i i l l r im~i~nLiauoini5~a ,~r i~uninoin& n7su?slB~B

waluniliaaoinir~ain~~nua:d~uln~n~iuauiniud~n~uo~~i &&u Z k J l J ~ ~ ~ i ~ m i i J o i n n i ~ ~ d s ~ ~ i u o i n ~ ~ i ~ o lnd q n?r.iadr:uinr 30 uifl rdosa~rioinirdou i l o s n ' u b ~ $ ~ 8 w n o n ~ ?

r d o f l a i n i ~ o o ~ n uano in~~ i l ryy i lmu7 dl~~dsrmuuzniut11~n~uro8~o doussniu~Idr&u~&naiu nqo n~ iunui iuu~u~r:n ium~t~ iu s ~ ~ ~ i ~ u i u ~ a ~ d o i n ~ i o ~ ~ i ~ ~ ~ y nBirw ~ ~ d s m i u ~ ~ d ~ f i i u u a : : o i n i s ~ v ~ ~ n ~ ~ slqrai~?nu oini~fia~~niin~uonnian!daaon : : ~ I , ~ s I ,

..,. ,... !i!{il ,. n,.... ,:!1::::t. .::it! i du7 .., : $ d o d ~ ~ u n ? i u ~ ~ n i w . g ( ~ ~ ~ 7 i 0

n7snnaouqn@ubol@o Human Immunodeficiency Virus uwaqulurs 2" t

nisnr~ouqnauuuado HN 3oar;uIws r8uni.j 3"6sirou nnaau~unaonnnao~dsznou6au nimol~nnfi.luuaaayu (I) n i ~ n i f i u i r u r ~ o HIV

Iwsdoraa&5nriionvia~Ga T-cell d ~ 8 o ~ I h a n n n a o ~ Gi i& HIV uir$oaia 10 fold dilution &'~U?IUI d t o r ~ i ~ a w ~ r n a ~ u r G u ~ u ~ o ~ a ~ u ~ ~ d ~ i ~ a a i u i l u f i ~ d a L&,JL'bag&j 10% FBS L;uL$a HIV+jl~aP1JU~2 aRPlu

d r r a a i u i ~ ~ n ~ s n ~ a o u ~ n r n i u I ~ i ~ & ~ ' ~ ~ ~ u ~ y u h s d i i f i ~ nla 96 nalULqoOl.)az 4 n?u uRL';u MT4 cells d

dor.aa~~a~sl;r~nnaouIu~u~oud~Ir~ uazni.jnnaouqna (1~106 Laa~uI.) ~Ud~UIRJS;L~l~u gl\doudqwnn; k

~ o ~ ~ ~ u ~ s i t J a ? n n ~ ~ n i s ~ ' u i ~ n i ~ ~ o l ~ B o ~ o ~ I a i u (anti-viral 37 oJRllraRIQur, 5% nl%usPilgoonIa& ulu 5 7% t

infectivity) r r a r n i ~ ~ u o a n i ~ ~ d u i i u 3 u I a i ~ (anti-viral LTa~S1ULLdlrYlqUUlC17aqP17 HI" antigen g-,oi+ replication) ~ n o ~ ~ ~ r B o I - , i a ~~azu;ubsrdaIntni~~'u tt lmmuno+-,uorescence assay (IFb) URtilU7mfialmbjR

uazurmrratininn~ou~uquIws r6oIv~unisu'~ian1r rgu TCID50/ml ~ i n n u ~ ~ o J Reed an,, Musnch - . rui$.na$~oal?ic na'~o~niu~~reli?uwau$~n~null;i'u~ (2) nisnnanunaiu~flui;l~~o~ai.jan'nayu~w.jd~ -.

z ~ u ~ ~ I u ~ i o ~ r ~ u ~ r ~ a a ' d ~ a ; u l w ~ w r u o ~ rdo~%al?oilw.r Laa&uJlunaomnwaoJ . .

~ u f ~ n i ~ ~ d u ~ i ~ ? u ~ a i a ~ u r a a ~ ~Ain~aouaiFdaluuas r~iruumra:a~u~isnn'~a~uIws~n~~uru'uuiroi~o$~ -lp,r-

. . lajkuuR-~~.aati Iao% l m m ~ n 0 f l ~ o r e ~ ~ 8 n ~ e assay ([FA) &:CIOIL$UJlqag ~ l ~ ~ L ~ U J 1 2 P J ~ y L a a MT-4 i5r!pi ~a:ku?runi1~~5u1nilaibPg;~~~~l~aaainr~n~a~u~w5l~uu L'bagluh,) audqnrnp~ 37 atnlrlaL~Ui>

- .- 1 ~ 1 1 nl&aQlmoonIr$ uiu 5 7% $lLraaunng%yj@ mad r i i p l ~ ~ u ( 1 w s d n a i u ~ . U I ~ . U I ~ 6 i i ~ ~ u i ~ ~ ~ j ? ~ . t ~ ~ ~ ~ ~ . . .

CaSBols Tau% Trypan blue dye exclusion &$t.#$~-pt\ b.naBd'Launirnnrou Ihri MT4 cells ~ i lu HTLV- iOuRrVOJlaS~aRaJ (% cell reduction) , he r :h " . y l

. . ,A 4 1- carrying adult T-cell leukemia cell line ha: MOLT-4 laIgdr~ualu& ullf uRP L a a ~ d l ~ ~ r 1 5 g w o

IHTLVlllB cells 18% continuous HTLV-Ill producer (control) n?lulfi~oJR~ulW'IdilUaIM r t fl

MOLT-4 cells rraanr~arr~m8urIuXui~io~raaEi nil 2oa ~ o n a r u l ~ u + w o r R u u ~ w S ~ o Z ~ l ~ r l w r ~ t i n ~ RPMI-1640 medium [Hyclone, Utah, USA] dfj 10% ojfjJl& fefal bovine serum (FBS) [Hyclone, Utah, USA]

ran HIV % Cell reduction = A 4 xlo~ A

leisonoin MOLT-41 HTLVlllB cells b u t i u ~ r d u . , . A no. of viable cells in control , .

d i u ~ u ~ . a a i S l u ~ ~ u i r ~ u ~ ~ r a a i d ~ l o % FBS L ~ U L ~ R ? 7 B = No..oTviable cells in test well . .

iu 1% cell-free culture fluid d -80 oJfliLaa1quR rbn:: n s a ~ f fiulnrr#o HIV Iau HIV infectivity assay iinriau d.. t - , . . . ,

~ 8 % TCID 501m1 (3) nimnaou.qnmuesr~o HIV lunaean$a&'- ::.

' 8 4- J ~ a i s a ~ a i u ~ . r ~ n ' n r ~ u I w s d n a ~ u ~ . U I n ~ ~ ~ ~ ~ ~ $ u :

N~MIMT i;ludolraii wau~ur4o HIV dr i iu i r~aaia 10 rvi l ~7.g.:

~ n l ~ ~ ~ d ~ ~ d ~ ~ ~ l ~ r n ' n n ' o l (extract) ~~L&~~B:@?uGI fold dilution) ~ ~ ~ 1 ~ 1 L ~ ~ ~ l ' b ~ ~ d ~ 20% FBS ~ a o ~ a ~ : V m.rdI~ri inryubsI~rrr i Ji romuoa naobAoiu ~a R~u'LWT n'ul-~iu l ~ r J5u in~nd~Miu dn-~ iu~ ioa i~az * -' : Bao:+~oln L ~ ~ U B ~ U B I S ~ ~ ~ B ~ F ~ I O ~ R ~ I ~ ~ I ~ O J L ~ ~ L I U I U ~ I J ' nqu Zunia 96 nqu u a : l a ? 0 ~ 1 ~ ~ / ' ~ ~ - 4 - (2x10~

R15WRU polyvinylpyrrolidone 40,000 (PVP-40) l%s&~a.) uuuiiums~n"na~~"rw~~~,i;aanw~i~.'~d'1~1~b~,

U1 AZT

r r i AZT njo Zidovudine (3'-azido- n i rpnnqu $1 B'deoxythymidine ) L ~ U anti-HIV agent d ~ i U i S n ~ R ; l 37

(Inhibition of Infection) ~ ~ a : ~ u ~ a n ~ a r ~ u i ~ u a u assay (IF@. (Inhibition of replition)

g::!::',.::, '.. , , .-- . . w t h 3 arnIBr3!%Bm~7a&i%im~ n s u ~ m a ~ 1 ._ I .".I..."

. .. .. .-.-..-- WI 5 OM 3 n m p u - m u 2551

- X . . . .-. . .--- A..~..-.. _ >...... -. ~ -- . . . .

anaaain virus control (% reduction of HIV infectivity)

msr~nrr?u!wsdmuis~u'uf~'1~ir'1n' 90% auld 6a i i b.. * d urneqnaouujr.aa HIV hnaann~aoa uaznimnasuyn

mta ~$3uurfiauKun.r~iin9in 01 ~ z r

evidence for origin of thymusderived lymphocytes.

J Nail Cancer 1972; 49:891-895.

Johnson VA. "Quantitative assay for virus Infectivity."

And 'Evalution of candidate anti-HIV agents in

% Reduction of HIV infectivity = &Q xlOO C

C = TCID50lml of virus wntml

D = TClD50iml of sample

lmmunofluorescence assay (IFA) -. ?aas?%Ml HiV antigen n j u i f IFA <1b%a6 MT4

luuoiazngu il iua~uxdaR' 6 a l f l & t r k ~ d ~ w v l ~ ~ r k a + ~ i n ~ u u $ d a & m 4 T ~ d h ~ ' n UIU 10 ar-~fi ud~'1-F I%u$J HIV antibody w v e human serum d~9m1~ ~umsaralu PBS d$ 1% Bovine serum albumin bWk

'ldaudqnanc~%o uiu 1 h l u a a ~ n ~ u < i r i l a & i h ~ $30 PBS daus8u FlTC conjugated rabbit anti-Human

I ~ G drqooia 1:200 iumrazaiu PBS kii 1% Bovine

serum albumin uhril!dau d~?nrvl~iirkaa ulu 40 ulfi un:riiu16i~humsa~aiu PBS nun mounting medium

a~uua'1aC uazQ~n'?u mver slip G ~ a I ~ d ~ J ~ l n a v l i nis r~s~ua~d$an~srr.~~udv~a HIV antigen draei MT4 &u ngar Fluorescence

b" t 3irnnaouqnauuu~~4a HIV d ~au3%uiasyu la'

r-~aidsruiw 2 Zd~l16 ~lliiiivlaiu$u:~lau d ~ ~ i a ? = l J

t t ln'%nuvu ua:n~snnrraunraungu~~nisu'uo~~~i~ C U Z ~

oiuonr%aa' (active stage) rra: .r:ozw"nod!uiraa' dr tY

(latent stege) ~ s r i 7 u i ~ ~ u n i s n ' ~ n s o ~ ~ n ~ u u u ~ ~ ~ o HIV

uo~a~u'lvrsda~%az~1dnu~1w'Lun1s~%nwi~~n~a~~ riau d o : d ~ d $ n i s # n ~ o ~ 6 d ? ~ n ~ u ~ o~ms&%!Jlua~u'1w5 n?ailnmn?iul~ufib~u~nin~aad nis%~uir0uoi uar nisi%un8Bnlunu6ia'1d

vitro". In Techniques in HIV Research. Stockton

Press. U.S.A., ISBN#O-935859-76-4, page 71-

76. and page 225-237. i Ohki K, Kimura T, Ohmura K, Morikawa Y, Jones IM,

Azuma I, et al. Monoclongl antibodies to a CD4

peptide derivative which includes the region

corresponding to an immunoglobulin CDR3:

Evidence of the involvement of pre-CDR3-related

region in HIV-1 and host cell interaction

MoMular immunology. 1%2; 291391-1400.

lylifsuya H, Weinhold KJ, Furman PA, St. Clair MH,

Lehfman SN, Gallo RC, e l al. 8'-Azido-3'-

dewythymidine (BWA5OA): an ahtiviral agent that

inhibits the i n f e c t i i and Cyropalhic effect of human

T-lymphotropio virus type Illllymphadenopathy-

associated virus in vitm. Proc Natl Acad Sci LISA

1985; 82:70967100.

Nakashima H, Matsu~ T, Harada S. Kobayashi N,

Matsuda A, Ueda T et ai. Inhibition of replication

and cytopalhic effect of human T cell iymphotmpic

virus type lllllymphadenopathy-associated virus by

3'-Azido-3'-deoxythymidine in vitro. Antimicro

Agents Chemother 1986; 30:933.937.

Miyoshi I, Taguchi H, Kubonishi 1 61 al. Type C virus-

producing cell lines derived from adult T cell

leukemia. Gann Monogr 1982; 28:219-228.

Minowada J, Ohnuma T, Moore GE. Rosette fopning

human lymphoid cell lines. I. Establishment and

:: , , . . . . . w .. ,.... , : . . . !- --- . .

(h-Qllvldlso-

I ; . . I . Ins. 02-9610000-11 h O - W f *